Edition:
United Kingdom

Trinity Biotech PLC (TRIB.OQ)

TRIB.OQ on NASDAQ Stock Exchange Global Select Market

5.55USD
23 Feb 2018
Change (% chg)

$-0.04 (-0.72%)
Prev Close
$5.59
Open
$5.62
Day's High
$5.72
Day's Low
$5.55
Volume
2,639
Avg. Vol
9,553
52-wk High
$6.33
52-wk Low
$4.30

Chart for

About

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the... (more)

Overall

Beta: 1.45
Market Cap(Mil.): $128.62
Shares Outstanding(Mil.): 24.04
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.91 10.66
ROE: -- 16.41 14.30

BRIEF-Trinity Biotech reports Q3 earnings per share $0.063

* Q3 revenue $25.6 million versus I/B/E/S view $26.1 million Source text for Eikon: Further company coverage:

26 Oct 2017

Competitors

  Price Chg
Tosoh Corporation (4042.T) ¥2,256 +54.00
Siemens AG (SIEGn.DE) €110.72 +0.18
Johnson & Johnson (JNJ.N) $132.02 +2.11
Roche Holding Ltd. (ROG.S) CHF222.05 -1.25
Roche Holding Ltd. (RO.S) CHF225.80 -0.60
Abbott Laboratories (ABT.N) $59.71 +0.72
Bayer AG (BAYGn.DE) €97.92 -0.52
Bayer AG (BAYE.F) -- --
Thermo Fisher Scientific Inc. (TMO.N) $211.71 +2.58
Alere Inc (ALR) 83.40zł -0.10

Earnings vs. Estimates